ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ZYNE Zynerba Pharmaceuticals Inc

1.30
0.00 (0.00%)
取引時間後
最終更新日: 09:00:00
15分遅延
名称 銘柄コード 市場 種別
Zynerba Pharmaceuticals Inc ZYNE NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 1.30 09:00:00
始値 安値 高値 終値 前日終値
1.30 1.30
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/2/0909:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/10/2005:48EDGAR2Form 15-12G - Securities registration termination [Section..
2023/10/1213:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/10/1123:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1123:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1123:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1123:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1122:27EDGAR2Form POS AM - Post-Effective amendments for registration..
2023/10/1122:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
2023/10/1121:56EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
2023/10/1121:31EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
2023/10/1121:17EDGAR2Form 8-K - Current report
2023/10/1121:00PRNUSHARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA..
2023/10/0506:29EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
2023/10/0505:05GLOBEImportant Information for Zynerba Pharmaceuticals..
2023/9/2922:00GLOBEZynerba Pharmaceuticals Stockholders Reminded to Tender..
2023/9/2721:25EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
2023/9/2721:12EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
2023/9/2721:00PRNUSHARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO..
2023/9/1521:00EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
2023/9/1505:59EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
2023/9/1505:16EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
2023/9/1505:15GLOBEZynerba Pharmaceuticals Presents Positive Data from Phase 2..
2023/9/1505:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1505:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0605:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/8/3005:05EDGAR2Form 8-K - Current report
2023/8/2822:05EDGAR2Form SC 14D9 - Solicitation, recommendation statements
2023/8/2821:23EDGAR2Form SC TO-T - Tender offer statement by Third Party
2023/8/2506:23EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2023/8/1605:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/1506:29EDGAR2Form SC TO-C - Written communication relating to an issuer..
2023/8/1506:26EDGAR2Form SC TO-C - Written communication relating to an issuer..
2023/8/1506:20EDGAR2Form SC14D9C - Written communication relating to third party..
2023/8/1420:45EDGAR2Form SC14D9C - Written communication relating to third party..
2023/8/1420:42EDGAR2Form 8-K - Current report
2023/8/1420:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1420:30PRNUSHARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.
2023/8/0905:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/8/0905:05GLOBEZynerba Pharmaceuticals Announces New Date for Reconvened..
2023/7/2606:24EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/7/2606:18GLOBEZynerba Pharmaceuticals Announces New Date for Reconvened..
2023/6/2905:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/6/2905:05GLOBEZynerba Pharmaceuticals Announces Further Adjournment of..
2023/6/2020:00GLOBEZynerba Pharmaceuticals to Present at the H.C. Wainwright..
2023/6/1405:05GLOBEZynerba Pharmaceuticals Announces Partial Adjournment of..
2023/5/2320:00GLOBEZynerba Pharmaceuticals Announces Podium and Poster..
2023/5/1520:00GLOBEZynerba Pharmaceuticals Reports First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock